Palatin Technologies (PTN) Capital Leases (2011 - 2023)
Palatin Technologies' (PTN) quarterly Capital Leases came in at $18527.0 in Q3 2023, down 85.33% on a YoY basis from $126333.0 in Q3 2022, and down 59.74% quarter-over-quarter from $46014.0 in Q2 2023.
Powered by 
Analysis
Palatin Technologies (PTN) Capital Leases (2011 - 2023) Analysis & Trends
Palatin Technologies (PTN) has reported Capital Leases for 7 consecutive years, with $18527.0 the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Capital Leases fell 85.33% year-over-year to $18527.0; the trailing twelve-month figure through Sep 2023 stood at $18527.0 (down 85.33% YoY), and the FY2023 full-year result was $46014.0, down 69.81% from the prior year.
- Capital Leases slipped to $18527.0 in Q3 2023 per PTN's latest filing, from $46014.0 in the prior quarter.
- Across five years, Capital Leases topped out at $178139.0 in Q1 2022 and bottomed at $18527.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 18,527.00 |
| Jun 30, 2023 | 46,014.00 |
| Mar 31, 2023 | 73,141.00 |
| Dec 31, 2022 | 99,912.00 |
| Sep 30, 2022 | 126,333.00 |
| Jun 30, 2022 | 152,407.00 |
| Mar 31, 2022 | 178,139.00 |
| Sep 30, 2016 | 7,214.00 |
| Jun 30, 2016 | 14,324.00 |
| Jun 30, 2015 | 41,749.00 |
| Mar 31, 2013 | 2,048.00 |
| Dec 31, 2012 | 8,116.00 |
| Sep 30, 2012 | 14,068.00 |
| Jun 30, 2012 | 19,909.00 |
| Mar 31, 2012 | 25,638.00 |
| Dec 31, 2011 | 31,260.00 |
| Sep 30, 2011 | 36,775.00 |
| Jun 30, 2011 | 42,186.00 |